1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anti-Emetic Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Anti-Emetic Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Injection
1.4.4 Others
1.5 Market by Application
1.5.1 Global Anti-Emetic Drug Market Share by Application: 2021-2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Home Care
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Anti-Emetic Drug Market
1.8.1 Global Anti-Emetic Drug Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Anti-Emetic Drug Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Anti-Emetic Drug Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Anti-Emetic Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Anti-Emetic Drug Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Anti-Emetic Drug Sales Volume Market Share by Region (2015-2020)
3.2 Global Anti-Emetic Drug Sales Revenue Market Share by Region (2015-2020)
3.3 North America Anti-Emetic Drug Sales Volume
3.3.1 North America Anti-Emetic Drug Sales Volume Growth Rate (2015-2020)
3.3.2 North America Anti-Emetic Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Anti-Emetic Drug Sales Volume
3.4.1 East Asia Anti-Emetic Drug Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Anti-Emetic Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Anti-Emetic Drug Sales Volume (2015-2020)
3.5.1 Europe Anti-Emetic Drug Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Anti-Emetic Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Anti-Emetic Drug Sales Volume (2015-2020)
3.6.1 South Asia Anti-Emetic Drug Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Anti-Emetic Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Anti-Emetic Drug Sales Volume (2015-2020)
3.7.1 Southeast Asia Anti-Emetic Drug Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Anti-Emetic Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Anti-Emetic Drug Sales Volume (2015-2020)
3.8.1 Middle East Anti-Emetic Drug Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Anti-Emetic Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Anti-Emetic Drug Sales Volume (2015-2020)
3.9.1 Africa Anti-Emetic Drug Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Anti-Emetic Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Anti-Emetic Drug Sales Volume (2015-2020)
3.10.1 Oceania Anti-Emetic Drug Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Anti-Emetic Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Anti-Emetic Drug Sales Volume (2015-2020)
3.11.1 South America Anti-Emetic Drug Sales Volume Growth Rate (2015-2020)
3.11.2 South America Anti-Emetic Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Anti-Emetic Drug Sales Volume (2015-2020)
3.12.1 Rest of the World Anti-Emetic Drug Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Anti-Emetic Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Anti-Emetic Drug Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Anti-Emetic Drug Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Anti-Emetic Drug Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Anti-Emetic Drug Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Anti-Emetic Drug Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Anti-Emetic Drug Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Anti-Emetic Drug Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Anti-Emetic Drug Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Anti-Emetic Drug Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Anti-Emetic Drug Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Anti-Emetic Drug Sales Volume Market Share by Type (2015-2020)
14.2 Global Anti-Emetic Drug Sales Revenue Market Share by Type (2015-2020)
14.3 Global Anti-Emetic Drug Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Anti-Emetic Drug Consumption Volume by Application (2015-2020)
15.2 Global Anti-Emetic Drug Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Anti-Emetic Drug Business
16.1 Merck
16.1.1 Merck Company Profile
16.1.2 Merck Anti-Emetic Drug Product Specification
16.1.3 Merck Anti-Emetic Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Mylan
16.2.1 Mylan Company Profile
16.2.2 Mylan Anti-Emetic Drug Product Specification
16.2.3 Mylan Anti-Emetic Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 F. Hoffmann-La Roche
16.3.1 F. Hoffmann-La Roche Company Profile
16.3.2 F. Hoffmann-La Roche Anti-Emetic Drug Product Specification
16.3.3 F. Hoffmann-La Roche Anti-Emetic Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Novartis
16.4.1 Novartis Company Profile
16.4.2 Novartis Anti-Emetic Drug Product Specification
16.4.3 Novartis Anti-Emetic Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Aurobindo Pharma
16.5.1 Aurobindo Pharma Company Profile
16.5.2 Aurobindo Pharma Anti-Emetic Drug Product Specification
16.5.3 Aurobindo Pharma Anti-Emetic Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Glenmark Pharmaceuticals
16.6.1 Glenmark Pharmaceuticals Company Profile
16.6.2 Glenmark Pharmaceuticals Anti-Emetic Drug Product Specification
16.6.3 Glenmark Pharmaceuticals Anti-Emetic Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Akorn
16.7.1 Akorn Company Profile
16.7.2 Akorn Anti-Emetic Drug Product Specification
16.7.3 Akorn Anti-Emetic Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Kyowa Kirin
16.8.1 Kyowa Kirin Company Profile
16.8.2 Kyowa Kirin Anti-Emetic Drug Product Specification
16.8.3 Kyowa Kirin Anti-Emetic Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Heron Therapeutics
16.9.1 Heron Therapeutics Company Profile
16.9.2 Heron Therapeutics Anti-Emetic Drug Product Specification
16.9.3 Heron Therapeutics Anti-Emetic Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Hikma
16.10.1 Hikma Company Profile
16.10.2 Hikma Anti-Emetic Drug Product Specification
16.10.3 Hikma Anti-Emetic Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Sun Pharmaceutical Industries
16.11.1 Sun Pharmaceutical Industries Company Profile
16.11.2 Sun Pharmaceutical Industries Anti-Emetic Drug Product Specification
16.11.3 Sun Pharmaceutical Industries Anti-Emetic Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Dr. Reddys Laboratories
16.12.1 Dr. Reddys Laboratories Company Profile
16.12.2 Dr. Reddys Laboratories Anti-Emetic Drug Product Specification
16.12.3 Dr. Reddys Laboratories Anti-Emetic Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Teva Pharmaceutical
16.13.1 Teva Pharmaceutical Company Profile
16.13.2 Teva Pharmaceutical Anti-Emetic Drug Product Specification
16.13.3 Teva Pharmaceutical Anti-Emetic Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Wockhardt
16.14.1 Wockhardt Company Profile
16.14.2 Wockhardt Anti-Emetic Drug Product Specification
16.14.3 Wockhardt Anti-Emetic Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Cipla
16.15.1 Cipla Company Profile
16.15.2 Cipla Anti-Emetic Drug Product Specification
16.15.3 Cipla Anti-Emetic Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 Pfizer
16.16.1 Pfizer Company Profile
16.16.2 Pfizer Anti-Emetic Drug Product Specification
16.16.3 Pfizer Anti-Emetic Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.17 Fresenius Kabi
16.17.1 Fresenius Kabi Company Profile
16.17.2 Fresenius Kabi Anti-Emetic Drug Product Specification
16.17.3 Fresenius Kabi Anti-Emetic Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Anti-Emetic Drug Manufacturing Cost Analysis
17.1 Anti-Emetic Drug Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Anti-Emetic Drug
17.4 Anti-Emetic Drug Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Anti-Emetic Drug Distributors List
18.3 Anti-Emetic Drug Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Anti-Emetic Drug (2021-2026)
20.2 Global Forecasted Revenue of Anti-Emetic Drug (2021-2026)
20.3 Global Forecasted Price of Anti-Emetic Drug (2015-2026)
20.4 Global Forecasted Production of Anti-Emetic Drug by Region (2021-2026)
20.4.1 North America Anti-Emetic Drug Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Anti-Emetic Drug Production, Revenue Forecast (2021-2026)
20.4.3 Europe Anti-Emetic Drug Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Anti-Emetic Drug Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Anti-Emetic Drug Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Anti-Emetic Drug Production, Revenue Forecast (2021-2026)
20.4.7 Africa Anti-Emetic Drug Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Anti-Emetic Drug Production, Revenue Forecast (2021-2026)
20.4.9 South America Anti-Emetic Drug Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Anti-Emetic Drug Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Anti-Emetic Drug by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Anti-Emetic Drug by Country
21.2 East Asia Market Forecasted Consumption of Anti-Emetic Drug by Country
21.3 Europe Market Forecasted Consumption of Anti-Emetic Drug by Countriy
21.4 South Asia Forecasted Consumption of Anti-Emetic Drug by Country
21.5 Southeast Asia Forecasted Consumption of Anti-Emetic Drug by Country
21.6 Middle East Forecasted Consumption of Anti-Emetic Drug by Country
21.7 Africa Forecasted Consumption of Anti-Emetic Drug by Country
21.8 Oceania Forecasted Consumption of Anti-Emetic Drug by Country
21.9 South America Forecasted Consumption of Anti-Emetic Drug by Country
21.10 Rest of the world Forecasted Consumption of Anti-Emetic Drug by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer